Literature DB >> 2368438

Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy.

C Davies1, M J Demeure, A St John, A J Edis.   

Abstract

Patterns of intact (1-84) parathyroid hormone (intact PTH) elimination and subsequent recovery of parathyroid function were studied in 12 patients undergoing parathyroidectomy. Nine patients had primary hyperparathyroidism (HPT), with single gland disease in 6 and multiple gland disease in 3. Two patients had subtotal parathyroidectomy for HPT secondary to chronic renal failure and 1 underwent excision of a hyperfunctioning parathyroid autograft. Using a sensitive 2-site immunochemiluminometric assay, serum intact PTH levels were measured preoperatively, intraoperatively, and postoperatively. A dual phase pattern of hormone clearance was found in 10 of the 12 patients, including the patient undergoing autograft excision. A monoexponential clearance pattern was seen in the remaining 2 patients, both of whom had subtotal parathyroidectomies for multiple gland disease. In the patients with primary HPT due to single gland disease, the early phase of intact PTH clearance had a half-life (T1/2) of 3.3 (+/- standard deviation 0.9) minutes and a late T1/2 of 96.4 (+/- standard deviation 92.7) minutes. Calculation of decay curves and half-lives for the patients undergoing subtotal parathyroidectomy was more difficult because of the inherent uncertainty in determining time zero. Nevertheless, in all but 2 patients, the clearance pattern was biexponential and the T1/2 measurements were very similar to those encountered in patients with single-gland disease. In the 2 patients with monoexponential clearance, the T1/2 figures were 86.7 minutes and 26.7 minutes, respectively. In the patients undergoing parathyroidectomy for primary HPT, levels of intact PTH were lowest at 1-3 hours after surgery, recovering to normal in the majority of patients by 18-40 hours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2368438     DOI: 10.1007/bf01658526

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Clearance of exogenous parathyroid hormone in normal and uraemic man.

Authors:  S E Papapoulos; G N Hendy; S Tomlinson; I G Lewin; J L O'riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1977-09       Impact factor: 3.478

2.  Comparison of the performance and clinical utility of a carboxy-terminal assay and an intact assay for parathyroid hormone.

Authors:  A St John; C Davies; W J Riley; G N Kent; R C Brown; J P Aston; I Weeks; J S Woodhead
Journal:  Clin Chim Acta       Date:  1988-12-15       Impact factor: 3.786

3.  Treatment of primary hyperparathyroidism.

Authors:  D C Purnell; D A Scholz; L H Smith; G W Sizemore; M B Black; R S Goldsmith; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

4.  Effects of extracellular Ca++ and Mg++ on cytosolic Ca++ and PTH release in dispersed bovine parathyroid cells.

Authors:  D Shoback; J Thatcher; R Leombruno; E Brown
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

5.  A program for non-linear regression analysis to be used on desk-top computers.

Authors:  P Koeppe; C Hamann
Journal:  Comput Programs Biomed       Date:  1980-12

6.  Recovery of parathyroid hormone secretion after parathyroid adenomectomy.

Authors:  A R Brasier; C A Wang; S R Nussbaum
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

7.  Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay.

Authors:  R C Brown; J P Aston; I Weeks; J S Woodhead
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

8.  Parathyroid hormone: before and after parathyroidectomy.

Authors:  Q Y Duh; C D Arnaud; K E Levin; O H Clark
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

9.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

10.  Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone.

Authors:  I R Curley; M H Wheeler; J P Aston; R C Brown; I Weeks; J S Woodhead
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

View more
  8 in total

1.  Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal.

Authors:  Miguel Echenique Elizondo; Francisco Javier Díaz-Aguirregoitia; José Antonio Amondarain; Fernando Vidaur
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

2.  Comparison of 'intraoperative' parathormone measurement with frozen section during parathyroid surgery.

Authors:  W Madira; G S Robertson; N J London; S J Iqbal; P R Bell; P S Veitch
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

3.  Intrinsic limitations to unilateral parathyroid exploration.

Authors:  F D Moore; F Mannting; M Tanasijevic
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

Review 4.  Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

Authors:  Donovan Tay; Serge Cremers; John P Bilezikian
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

5.  Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; B Ahrén
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

6.  Parathyroid adenomectomy under local anesthesia with intra-operative monitoring of UcAMP and/or 1-84 PTH.

Authors:  Y Chapuis; P Icard; Y Fulla; L Nonnenmacher; P Bonnichon; A Louvel; B Richard
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

7.  Intraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; A Isaksson; B Ahrén
Journal:  Langenbecks Arch Chir       Date:  1994

8.  A 10-year experience in intraoperative parathyroid hormone measurements for primary hyperparathyroidism: a prospective study of 91 previous unexplored patients.

Authors:  M C Neves; M N Ohe; M Rosano; M Abrahão; O Cervantes; M Lazaretti-Castro; J G H Vieira; I S Kunii; R O Santos
Journal:  J Osteoporos       Date:  2012-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.